The Pediatric Treatment Gap in Inherited Retinal Diseases

Click here to watch the video version of this podcast.

>>>

Inherited retinal diseases can profoundly affect a child’s vision and development, yet there are no approved drug treatments for most of these conditions in children. In this episode of Eye on Innovation, host Carey Powers speaks with Carmen Caricchio, CEO and founder of RareSight, about why pediatric inherited retinal diseases have historically received less attention and investment than adult diseases — and how advances in genetic testing and clinical assessment are beginning to change that.

In this episode, learn about:
🔹Why treatments developed for adults cannot simply be applied to children
🔹Where gene therapy may fit into the future of care
🔹RareSight’s approach to developing treatments designed to remain in the eye longer
🔹How these treatments will change the trajectory of a child’s life

Resources:
Carey Powers: https://ois.net/carey-powers/
Carmen Caricchio: https://www.linkedin.com/in/carmen-caricchio/